Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine.
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine.
复制标题
DOI:
10.1111/bph.13505
复制
发表时间:
2016-07
影响因子:
7.3
通讯作者:
Sethi JK
中科院分区:
文献类型:
--
作者:
Grolla AA;Travelli C;Genazzani AA;Sethi JK
In this review, we focus on the secreted form of nicotinamide phosphoribosyltransferase (NAMPT); extracellular NAMPT (eNAMPT), also known as pre‐B cell colony‐enhancing factor or visfatin. Although intracellular NAMPT is a key enzyme in controlling NAD metabolism, eNAMPT has been reported to function as a cytokine, with many roles in physiology and pathology. Circulating eNAMPT has been associated with several metabolic and inflammatory disorders, including cancer. Because cytokines produced in the tumour micro‐environment play an important role in cancer pathogenesis, in part by reprogramming cellular metabolism, future improvements in cancer immunotherapy will require a better understanding of the crosstalk between cytokine action and tumour biology. In this review, the knowledge of eNAMPT in cancer will be discussed, focusing on its immunometabolic function as a metabokine, its secretion, its mechanism of action and possible roles in the cancer micro‐environment.